Price
No data yet.
Social Signal Score
Analyst Ratings
9 analystsRevenue
$673.25M+71.48%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Kevin J. McNamara
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Employees
- 15,811
- Beta
- 0.51
- Country
- US
- Piotroski score
- 7 / 9 (Strong)
- Altman Z-score
- 10.50
Financials
Revenue
$673.25M+71.5%Net Income
$67.70M+152.4%EBITDA
$101.42M+90.6%Free Cash Flow
$69.29M+53.4%EPS (diluted)
$5.13+216.7%Shares Outstanding (diluted)
13.42M-18.9%Operating Expenses
$115.20MCash & Debt
$40.22MReturn of Capital
$105.36MRevenue by Segment (annual)
$2.63BDividend per Share
$0.70Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $2.53B | $265.24M | $18.42 |
| 2024 | $2.43B | $302.00M | $20.10 |
| 2023 | $2.26B | $272.51M | $18.11 |
| 2022 | $2.13B | $249.62M | $16.72 |
| 2021 | $2.14B | $268.55M | $17.14 |
| 2020 | $2.08B | $319.47M | $20.02 |
| 2019 | $1.94B | $219.92M | $13.77 |
| 2018 | $1.78B | $205.54M | $12.80 |
| 2017 | $1.67B | $98.18M | $6.11 |
| 2016 | $1.58B | $108.74M | $6.64 |
| 2015 | $1.54B | $110.27M | $6.54 |
| 2014 | $1.46B | $99.32M | $5.79 |
| 2013 | $1.41B | $77.23M | $4.24 |
| 2012 | $1.43B | $89.30M | $4.72 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from CHE's reported EPS growth of 11.0% a year over 13 years.
- EPS in 5 years
- $31.04
- Implied price
- $713.96
- Return from $515.44
- 6.7% a year
To earn 15.0% a year on these assumptions you'd need to buy at $354.97 — -31.1% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 17 | 20 | 23 | 26 | 29 |
|---|---|---|---|---|---|
| 1.0% | -8.6% | -5.6% | -2.9% | -0.5% | 1.7% |
| 6.0% | -4.1% | -0.9% | 1.9% | 4.5% | 6.8% |
| 11.0% | 0.5% | 3.8% | 6.7% | 9.4% | 11.8% |
| 16.0% | 5.0% | 8.5% | 11.5% | 14.3% | 16.8% |
| 21.0% | 9.5% | 13.1% | 16.3% | 19.2% | 21.9% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
50+66.67%Social Signal Score
Mentions (10)
- Newsglobenewswire.com·20d ago·Neutral
Chemed To Report Third Quarter 2026 Earnings October 27, Related Conference Call To Be Held On October 28 CINCINNATI, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the third quarter ended September 30, 2026, on Tuesday, October 27, 2026, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m.
View source ↗ - News (RSS)financialpost·33d ago·Negative
Chemtrade Logistics Income Fund Declares September 2026 Distribution TORONTO — Chemtrade Logistics Income Fund (TSX: CHE.UN, OTCQX®: CGIFF) today announced that it has declared a cash distribution of $0.06 per unit for the month of September 2026 payable on October 30, 2026 to unitholders of record at the close of business on September 29, 2026. Holders of units who are non-residents of Canada […]
View source ↗ - Newsglobenewswire.com·34d ago·Neutral
Roto-Rooter Buys Largest Franchisee Territory CINCINNATI, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Roto-Rooter Services Company, a wholly owned subsidiary of Chemed Corporation ("Chemed") (NYSE: CHE) announced it has acquired the largest independent Roto-Rooter franchise, serving a population of approximately 11 million people, for $60.6 million.
View source ↗ - News (RSS)seekingalpha·35d ago·Positive
Chemed Corporation (CHE) Presents at 2026 Jefferies Healthcare Services and Technology Conference Transcript
View source ↗ - Newsseekingalpha.com·35d ago·Positive
Chemed Corporation (CHE) Presents at 2026 Jefferies Healthcare Services and Technology Conference Transcript Chemed Corporation (CHE) Presents at 2026 Jefferies Healthcare Services and Technology Conference Transcript
View source ↗ - News (RSS)financialpost·42d ago·Neutral
…an-Canadian Pharmaceutical Alliance (pCPA) and LEO Pharma Canada. This marks important progress toward access for adults with moderate to severe chronic hand eczema (CHE) whose disease is inadequately controlled with, or for […]
View source ↗ - News (Marketaux)manilatimes.net·43d ago·Neutral
Chemed Corporation to Present at the Jefferies 2026 Healthcare Services Conference CINCINNATI, Sept. 08, 2026 (GLOBE NEWSWI[+287 characters]
View source ↗ - Newsglobenewswire.com·43d ago·Neutral
Chemed Corporation to Present at the Jefferies 2026 Healthcare Services Conference CINCINNATI, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE) today announced that it will deliver a presentation at the Jefferies 2026 Healthcare Services and Technology Conference on Tuesday, September 15, 2026, at approximately 10:55 a.m.
View source ↗ - News (RSS)fool·45d ago·Negative
Chemed Executive Spencer Lee Sells 1,000 Shares for $541,040 The insider sold 1,000 shares but still holds nearly 14,000 shares.
View source ↗ - Newsfool.com·45d ago·Negative
Chemed Executive Spencer Lee Sells 1,000 Shares for $541,040 The sale occurred on Aug. 21 and was valued at approximately $541,000. The disposition reduced the executive's direct equity holdings by 7%.
View source ↗
Earnings
Tue, Oct 27(in 5 days)
Consensus estimate $6.39 per share
Typical surprise +0.7% (median, so one quarter with a near-zero estimate can't distort it)
- Tue, Jul 28$6.06 vs $5.60beat
- Thu, Apr 23$5.65 vs $5.30beat
- Wed, Feb 25$6.42 vs $7.02miss
- Tue, Oct 28$5.27 vs $5.39miss
- Tue, Jul 29$4.27 vs $4.78miss
- Wed, Apr 23$5.63 vs $5.55beat
Estimates and results for CHE via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by CHE officers and directors.
- Bought
- $83k
- Sold
- $17.0m
1 trade
19 trades
- Mcnamara Kevin Jsold
- Mcnamara Kevin Jsold
- Lee Spencer Ssold
- Mcnamara Kevin Jsold
- Mcnamara Kevin Jsold
- Grace Patrick Psold
- Lindell Andrea Rsold
- Walsh George J Iiisold
80 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Lisa C. McClainhouse · MI09 · disclosed Aug 13, 2025 (50d later)Buy$1,001 - $15,000
- Byron Donaldshouse · FL19 · disclosed Apr 15, 2025 (40d later)Sell$1,001 - $15,000
- Byron Donaldshouse · FL19 · disclosed Apr 15, 2025 (40d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Mar 6, 2024 (22d later)Sell$1,001 - $15,000
- Daniel Goldmanhouse · NY10 · disclosed Feb 24, 2023 (24d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Feb 7, 2023 (27d later)Buy$1,001 - $15,000
- Thomas Hawley Tubervillesenate · AL · disclosed Oct 15, 2021 (16d later)Sell$1,001 - $15,000
- Thomas Hawley Tubervillesenate · AL · disclosed Jul 23, 2021 (116d later)Buy$1,001 - $15,000
- Greg Gianfortehouse · MT00 · disclosed Nov 9, 2020 (27d later)Sell$1,001 - $15,000
- Donna Shalalahouse · FL27 · disclosed Apr 27, 2020 (308d later)Sell$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.